 | |
| Clinical data | |
|---|---|
| Other names | N,N-dimethyl-8-chloro-5-methoxy-1-aminotetralin |
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H18ClNO |
| Molar mass | 239.74 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Lometraline (INN; developmental code name CP-14,368) is a drug and an aminotetralin derivative.[1] A structural modification of tricyclic neuroleptics, lometraline was originally patented by Pfizer as an antipsychotic, tranquilizer, and antiparkinsonian agent.[2][3] However, it was instead later studied as a potential antidepressant and/or anxiolytic agent, though clinical studies revealed no psychoactivity at the doses used and further investigation was suspended.[1][4][5] Further experimental modifications of the chemical structure of lometraline resulted in the discovery of tametraline, a potent inhibitor of the reuptake of dopamine and norepinephrine, which in turn led to the discovery of the now widely popular antidepressant sertraline, a selective serotonin reuptake inhibitor (SSRI).[6]
The precursor ketone can undergo a Mannich reaction with pyrrolidine to yield CID:12348935. This specific agent had analgesic activity in the same range as morphine and was not antagonized by naloxone.[7][8]
References
- ^ a b Park S, Gershon S, Angrist B, Floyd A (February 1972). "Evaluation of an aminotetraline, CP 14.368, as an antidepressant". Current Therapeutic Research, Clinical and Experimental. 14 (2): 65–70. PMID 4401233.
- ^ Drake E (27 January 1994). Saunders pharmaceutical word book, 1994. W.B. Saunders Co. ISBN 978-0-7216-5254-2. Retrieved 27 April 2012.
- ^ United States. Patent Office (1972). "Lometraline: tranquillizer, anti-parkinson agent". Official gazette of the United States Patent Office: Patents. The Office. Retrieved 27 April 2012.
- ^ McMahon FG (1974). Psychopharmacological agents. Futura Pub. Co. ISBN 978-0-87993-052-3. Retrieved 27 April 2012.
- ^ Bayerische Julius-Maximilians-Universität Würzburg. Arbeitskreis für Schlafforschung (1973). The Nature of sleep. Die Natur des Schlafes. La nature du sommeil: International symposium, Würzburg, 23-26.9.1971. G. Fischer. ISBN 978-3-437-10295-0. Retrieved 27 April 2012.
- ^ Koe BK, Harbert CA, Sarges R, Weissman A, Welch WM (2006). "Discovery of sertraline (Zoloft®)". Archived from the original on 2014-12-30. Retrieved 2012-04-27.
- ^ Welch WM, Harbert CA, Sarges R, Stratten WP, Weissman A (May 1977). "Analgesic and tranquilizing activity of 5,8-disubstituted 1-tetralone Mannich bases". Journal of Medicinal Chemistry. 20 (5): 699–705. doi:10.1021/jm00215a016. PMID 853506.
- ^ Welch WM, Plattner JJ, Stratten WP, Harbert CA (March 1978). "Analgesic and tranquilizing activity of 5,8-disubstituted 2-aminomethyl-3,4-dihydronaphthalenes". Journal of Medicinal Chemistry. 21 (3): 257–63. doi:10.1021/jm00201a004. PMID 628000.
This page was last edited on 29 December 2023, at 15:20